ahlam1399
07-25-2015, 12:29 AM
UPDATE 2-AbbVie, Bristol-Myers get FDA **d for hep C treatments
July 24 (Reuters) - The U.S. Food and Drug Administration on Friday approved two treatments for less common forms of hepatitis C virus (HCV) infections.
http://rc.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/rc/1/rc.img (http://rc.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/rc/1/rc.htm)
http://rc.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/rc/2/rc.img (http://rc.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/rc/2/rc.htm)
http://rc.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/rc/3/rc.img (http://rc.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/rc/3/rc.htm)
http://da.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/a2.img (http://da.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/a2.htm)
http://adchoice.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/ach.img (http://adchoice.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/ach.htm)http://pi.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/a2t.imghttp://pi2.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/48694f2c/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=enxreKBzKvA:CxZVqYxEOu0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=enxreKBzKvA:CxZVqYxEOu0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=enxreKBzKvA:CxZVqYxEOu0:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=enxreKBzKvA:CxZVqYxEOu0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=enxreKBzKvA:CxZVqYxEOu0:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/enxreKBzKvA
July 24 (Reuters) - The U.S. Food and Drug Administration on Friday approved two treatments for less common forms of hepatitis C virus (HCV) infections.
http://rc.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/rc/1/rc.img (http://rc.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/rc/1/rc.htm)
http://rc.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/rc/2/rc.img (http://rc.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/rc/2/rc.htm)
http://rc.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/rc/3/rc.img (http://rc.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/rc/3/rc.htm)
http://da.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/a2.img (http://da.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/a2.htm)
http://adchoice.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/ach.img (http://adchoice.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/ach.htm)http://pi.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/a2t.imghttp://pi2.feedsportal.com/r/234566110151/u/49/f/654213/c/35217/s/48694f2c/sc/14/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/48694f2c/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=enxreKBzKvA:CxZVqYxEOu0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=enxreKBzKvA:CxZVqYxEOu0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=enxreKBzKvA:CxZVqYxEOu0:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=enxreKBzKvA:CxZVqYxEOu0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=enxreKBzKvA:CxZVqYxEOu0:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/enxreKBzKvA